¶ BIOTECanada
.png)
BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario.[1] It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.[2][3]
BIOTECanada and the University of Western Ontario jointly administer the Gold Leaf Awards, presented annually to individuals and organizations who are deemed to have made significant contributions to Canada's biotechnology sector.[4]
¶ History
The organization was incorporated in 1987 as the Industrial Biotechnology Association of Canada.[5]
Health Canada partnered with BIOTECanada in May 2012 to organize a summit on clinical and regulatory topics associated with biosimilars.[6] The event was held in association with the International Alliance for Biological Standardization, and was observed by representatives from the Patented Medicine Prices Review Board (PMPRB) and the Canadian Agency for Drugs and Technologies in Health (CADTH). Panelists included representatives from academia, regulatory bodies and industry, such as UMass Memorial Health, Janssen Pharmaceuticals, the Robarts Research Institute, Alberta Blue Cross, Mount Sinai Hospital and Sunnybrook Health Sciences Centre.[6:1]
In 2017, BIOTECanada published a report detailing proposed initiatives to use biotechnology to address issues including population growth, climate change, food security, health, and economic instability.[7] President and CEO Andrew Casey sent a letter in July 2017 to Innovation, Science and Economic Development Canada (ISED) proposing measures to offset costs of patent filings, and to reduce taxation on intellectual property revenues.[3:1]
¶ COVID-19
Several representatives of BIOTECanada participated as members and advisors in the COVID-19 Therapeutics Task Force convened by Innovation, Science and Economic Development Canada.[8] BIOTECanada participated in the Faster Together campaign to promote COVID-19 vaccines.[9]
In June 2022, BIOTECanada hosted the Canada Pavilion at the BIO International Convention, an annual biotechnology conference led by the Biotechnology Innovation Organization (BIO).[10]
¶ Organization
BIOTECanada is partnered with Avantor, Borden Ladner Gervais (BLG), Ontario Genomics,[11] Silicon Valley Bank (SVB), and Wilson Sonsini Goodrich & Rosati.[12] The organization is a supporting member of BioTalent Canada, a professional network for the biotechnology community.[2:1] It is also a member of the Biotechnology Innovation Organization (BIO),[13] and a founding institution of Clinical Trials Ontario.[14] It is a participating organization of the Virtual Biosecurity Center, an initiative of the Federation of American Scientists.[15]
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Andrew Casey | President and Chief Executive Officer[3:2] | - |
| Mark Lievonen | Board Chair (former)[16] | COVID-19 Vaccine Task Force, JML Advisory Services, Sanofi Pasteur, Council of Expert Advisors (CEA), Innovative Medicines Canada (IMC) |
| Anita Hammer | - | Pharmaceutical Advertising Advisory Board (PAAB)[17] |
¶ Members
Current and former member organizations of BIOTECanada include:[18][19][20]
- 3Sixty Public Affairs
- 35Pharma
- 48Hour Discovery
- A&C American Chemicals
- AbbVie
- AbCellera
- Abdera Therapeutics
- Ability Biologics
- Accel-Rx
- Actylis
- Acuitas Therapeutics
- Adapsyn Bioscience
- adMare BioInnovations
- Advanced Accelerator Applications
- Aegerion Pharmaceuticals
- Ag-West Bio
- Agricultural Institute of Canada (AIC)
- Agri-Food Innovation Council (AIC)
- Agrisoma Biosciences
- Akshaya Bio
- Alethia Biotherapeutics
- Alexandria Venture Investments
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Alpha Cancer Technologies
- Alpha Cognition
- Alpha9 Theranostics
- Altus Formulation
- AmacaThera
- Amgen
- AmorChem
- Amplitude Ventures
- Antibe Therapeutics
- Aplantix
- Appili Therapeutics
- Applied Pharmaceutical Innovation (API)
- AquaBounty
- Aquinox Pharmaceuticals
- Aramis Biotechnologies
- AREV Life Sciences
- Aspect Biosystems
- AstraZeneca
- AtomVie Global Radiopharma
- Atuka
- Augurex Life Sciences
- Aurinia Pharmaceuticals
- AusBiotech
- Avir Pharma
- Back Bay Life Science Advisors (BBLSA)
- Bayer
- Bayshore Specialty Rx
- BeiGene
- BELLUS Health
- BioAlberta
- BioAmber
- BioCanRx
- Biodextris
- Bioenterprise
- Biogen
- Bioindustrial Innovation Canada
- Bio-K Plus
- Biologics Manufacturing Centre (BMC)
- BioMarin
- BioMark Diagnostics
- BioNB
- BioNova Pharmaceuticals
- Biopharm Management
- BIOQuébec
- Bioscience Association Manitoba (BAM)
- BioSignal2
- BioTalent Canada
- BioTech New Zealand
- Biotechnology Innovation Organization (BIO)
- BIOVECTRA
- Blake, Cassels & Graydon
- Blanchard Law
- Bloom Burton & Co.
- BMS Group
- Bold Therapeutics
- Borden Ladner Gervais (BLG)
- BrevisRefero
- Bright Angel Therapeutics
- Bristol-Myers Squibb
- BSQUARED Capital
- Canadian Advanced Therapies Training Institute (CATTI)
- Canadian Alliance for Skills and Training in Life Sciences (CASTL)
- Canadian Glycomics Network (GlycoNet)
- Canadian Seed Trade Association (CSTA)
- Canadian Venture Capital & Private Equity Association (CVCA)
- Canurta
- Caprion Biosciences
- Cardiome Pharma
- case Market Access Consulting
- CBRE Group
- Ceapro
- Celator Pharmaceuticals
- Celgene
- Celverum
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Centre for Drug Research and Development (CDRD)
- Centre for Probe Development and Commercialization (CPDC)
- Centre for the Commercialization of Antibodies and Biologics (CCAB)
- Chelation Partners
- Chinook Therapeutics
- CO2 Solutions
- Consortium de recherche biopharmaceutique (CQDM)
- Contextual Genomics
- Critical Outcome Technologies
- CryoStasis
- CSL Behring
- CSL Seqirus
- CTI Life Sciences Fund
- Cura Therapeutics
- Cyclenium Pharma
- Cynapsus Therapeutics
- Daiichi-Sankyo
- Dalton Pharma Services
- Defence Therapeutics
- DelMar Pharmaceuticals
- Deloitte
- Domain Therapeutics
- Drug Development and Innovation Centre (DDIC)
- Eisai
- Eli Lilly
- Encycle Therapeutics
- enGene
- Entos Pharmaceuticals
- Epitopea
- Ernst & Young (EY)
- ESSA Pharma
- EVERSANA
- Evolution for Animal Health (EVAH)
- Evolve Therapeutics
- ExCellThera
- Farris
- Fasken Martineau DuMoulin
- Feldan Therapeutics
- Ferring Pharmaceuticals
- FGS Longview
- Fibrocor Therapeutics
- Find Therapeutics
- Fonds de solidarité FTQ
- Formation Biologics
- FORUS Therapeutics
- Fusion Pharmaceuticals
- Genentech
- GenePOC
- Genesys Capital
- Genome Canada
- Genvira Biosciences
- Genzyme
- Giiant Pharma
- Gilead Sciences
- Global Public Affairs
- GMD Pharma Solutions
- GoodCap Pharmaceuticals
- Gowling WLG
- Grifols
- Guthrie Insurance Brokers
- HDAX Therapeutics
- Highland Therapeutics
- Horizon Pharma
- HTuO Biosciences
- Immugenia
- Immune Biosolutions
- ImmunoCalyx
- ImStar Therapeutics
- IMV
- Incyte
- Innovation PEI
- Innovative Targeting Solutions
- InnovoXL
- InSymbiosis Management
- Integrated Nanotherapeutics
- Inteligex
- Intercept Pharmaceuticals
- International Centre for Infectious Diseases (ICID)
- Intrinsik Health Sciences
- Inversago Pharma
- Iprogen Biotech
- Ipsen Biopharmaceuticals
- IQVIA
- IRICoR
- iTP Biomedica
- Janssen
- Jazz Pharmaceuticals
- JLABS
- JN Nova
- JPMorgan Chase
- Kaléo
- KalGene Pharmaceuticals
- Kane Biotech
- Kapoose Creek Bio
- KisoJi Biotechnology
- Kisolite
- KMT Hepatech
- KOP Therapeutics
- Korea Biotechnology Innovation Organization
- KPMG
- KreaMedica
- Langara College
- Laurent Pharmaceuticals
- Life Sciences British Columbia
- Life Sciences Ontario
- Linnaeus Plant Sciences
- LQT Therapeutics
- Lumira Ventures
- Mallinckrodt Pharmaceuticals
- Mannin Research
- MaRS Discovery District
- McDougall Scientific
- McKesson Canada
- ME Therapeutics
- MEDEC
- MedGenesis Therapeutix
- Medicago
- Medicenna Therapeutics
- Medicure
- Mediphage Bioceuticals
- Medlior Health Outcomes Research
- Medtech Canada
- Medunik Canada
- Medwell Capital
- Merck
- MSI Methylation Sciences
- Microbion Pharma
- Milestone Pharmaceuticals
- Mitsubishi Tanabe
- Modelis
- Moderna
- Molecular Forecaster
- MORSE Consulting
- Nanology Labs
- Nanovista
- National Research Council Canada (NRC)
- Neolys Pharma
- NEOMED Institute
- Neova Technologies
- NervGen Pharma
- Neurenati Therapeutics
- Neurodyn Life Sciences
- Newfoundland and Labrador Association of Technology Industries (NATI)
- Noa Therapeutics
- Nobelex Biotech
- Northern Biologics
- Northwest Biotherapeutics
- Norton Rose Fulbright
- Notch Therapeutics
- Novartis
- Novavax
- Novicol Life Sciences
- Novo Nordisk
- Oak Bay Biosciences
- Okanagan Specialty Fruits
- Oncolytics Biotech
- Ontario Bioscience Innovation Organization (OBIO)
- Optigo Biotherapeutics
- Orion Biotechnology
- Pangaea Group
- Pan-Provincial Vaccine Enterprise (PREVENT)
- Patient Access Solutions
- Pattern Pharma
- PBR Laboratories
- PDCI Market Access
- Pegasus Biotech
- Pfizer
- Phenomic AI
- Phoenix Molecular Designs
- Pholoho Biotechnology
- PlantForm
- POS Bio-Sciences
- Precision NanoSystems
- PreciThera
- Prevtec Microbia
- Primary Peptides
- Prince Edward Island BioAlliance
- Pro Bono Bio
- ProMIS Neurosciences
- ProNAi Therapeutics
- PROOF Centre of Excellence
- ProteinQure
- Proteocyte Diagnostics
- Qu Biologics
- Quality & Compliance Services
- Quark Venture
- QurCan Therapeutics
- Radiant Biotherapeutics
- Raptor Pharmaceuticals
- Reciprocal Space
- Red Leaf Medical
- Renaissance BioScience
- Repare Therapeutics
- RepliCel Life Sciences
- Replikins
- Research Canada
- Research New Brunswick
- Resverlogix
- Ripple Therapeutics
- ROCADE Investments
- Roche
- Roubaix Strategies
- Royal Bank of Canada (RBC)
- Sanofi
- SaNOtize
- Sansero Life Sciences
- ScarX Therapeutics
- Scispot
- Seagen
- Seeds Canada
- SemaThera
- Seqirus
- Sequence Bio
- Sernova
- SeroGene Therapeutics
- Servier
- Shadow Lake Group
- Shoppers Drug Mart Specialty Health Network (SDMSHN)
- Sierra Oncology
- SignalChem Lifesciences
- Silicon Valley Bank (SVB)
- SinoVeda
- Smart & Biggar
- Soricimed Biopharma
- Sound Insurance Services
- Specific Biologics
- SPharm
- Spiderwort
- Sustained Therapeutics
- Swedish Orphan Biovitrum (Sobi)
- TACT Intelligence-conseil
- Taiho Pharma Canada
- Takeda Pharmaceuticals
- Tallc
- Targa Biomedical
- TEC Edmonton
- techNL
- Temple Therapeutics
- Tentarix Biotherapeutics
- Teralys Capital
- Tetra Bio-Pharma
- Teva Pharmaceuticals
- Therapure Biopharma
- Thrasos
- Thryv Therapeutics
- Tieös Pharmaceuticals
- Toronto Innovation Acceleration Partners (TIAP)
- Transbiotech
- Transition Therapeutics
- Trillium Therapeutics
- Triphase Accelerator
- Triple Hair
- Turnstone Biologics
- UCB
- Ultragenyx
- University Health Network (UHN)
- University of Guelph
- University of Manitoba
- University of Waterloo
- Valeant
- Valneva
- Vasomune Therapeutics
- VBI Vaccines
- Ventus Therapeutics
- VeriLuce Therapeutics
- Verity Pharmaceuticals
- Versant Ventures
- Vertex Pharmaceuticals
- viDA Therapeutics
- VIDO-InterVac
- Virica Biotech
- Virogin Biotech
- Viventia Bio
- VoxCell BioInnovation
- VWR International
- Wex Pharmaceuticals
- Wilson Sonsini Goodrich & Rosati
- Xagenic
- Xenon Pharmaceuticals
- Zenith Epigenetics
- Zucara Therapeutics
- Zymeworks
¶ Activities
BIOTECanada has provided notable funding to the C.D. Howe Institute.[21]
¶ External links
MacDonald, C. (2004). Business Ethics 101 for the biotech industry. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 18(2), 71–77. https://doi.org/10.2165/00063030-200418020-00001 ↩︎
BIOTECanada. BioTalent Canada. Retrieved September 1, 2022, from https://archive.vn/20220901170514/https://www.biotalent.ca/organizations/biotecanada-2/ ↩︎ ↩︎
Casey, A. (2017, July 17). RE: Canada’s New Intellectual Property Strategy. Innovation, Science and Economic Development Canada. https://web.archive.org/web/20220902053734/https://www.ic.gc.ca/eic/site/693.nsf/vwapj/BIOTECanada.pdf/$file/BIOTECanada.pdf ↩︎ ↩︎ ↩︎
BIOTECanada Gold Leaf Awards. University of Western Ontario. Retrieved September 1, 2022, from https://web.archive.org/web/20220901171104/https://www.uwo.ca/research/impact/awards/biotecanada_gold_leaf_awards.html ↩︎
BIOTECanada. Bioscience Association Manitoba. Retrieved September 1, 2022, from https://web.archive.org/web/20220901204111/https://www.biomb.ca/bioscape/303/biotecanada ↩︎
Kay, J., Feagan, B. G., Guirguis, M. S., Keystone, E. C., Klein, A. V., Lubiniecki, A. S., Mould, D. R., Nyarko, K. A., Ridgway, A. A. G., Trudeau, M. E., & Wang, J. (2012). Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012. Biologicals, 40(6), 517–527. https://doi.org/10.1016/j.biologicals.2012.09.010 ↩︎ ↩︎
The Science of Amazing Canada’s Biotech Ecosystem. (2017). BIOTECanada. https://web.archive.org/web/20220901204805/https://www.biotecanada-ecosystem.com/ ↩︎
Innovation, Science and Economic Development Canada. (2022, March 10). COVID-19 Therapeutics Task Force. Government of Canada. https://web.archive.org/web/20230427230210/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force ↩︎
Home. Faster Together. Retrieved November 29, 2022, from https://web.archive.org/web/20221129144335/https://fastertogether.ca/ ↩︎
Alberta at BIO International 2022. BioAlberta. Retrieved September 1, 2022, from https://web.archive.org/web/20220901171800/https://www.bioalberta.com/alberta-at-bio-international-2022 ↩︎
Other Partners. Ontario Genomics. Retrieved May 2, 2022, from https://www.ontariogenomics.ca/about-us/partners/other-partners/ ↩︎
About. BIOTECanada. Retrieved August 2, 2022, from https://web.archive.org/web/20220802194749/https://www.biotech.ca/about/ ↩︎
BIOTECanada. Biotechnology Innovation Organization. Retrieved June 21, 2024, from https://web.archive.org/web/20240621201653/https://www.bio.org/save/biotecanada ↩︎
Founding Institutions. Clinical Trials Ontario. Retrieved December 30, 2024, from https://web.archive.org/web/20241230212232/https://legacy.ctontario.ca/who-we-are-clinical-trials-ontario/founding-institutions/ ↩︎
BIOTECanada. Virtual Biosecurity Center. Retrieved September 1, 2022, from https://web.archive.org/web/20220901204417/https://www.virtualbiosecuritycenter.org/organizations/biotecanada/ ↩︎
J. Mark Lievonen. Vaccine and Infectious Disease Organization. Retrieved December 30, 2024, from https://www.vido.org/team/board-of-directors/mark-lievonen ↩︎
About. Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité Pharmaceutique. Retrieved August 28, 2022, from https://web.archive.org/web/20220828145658/https://www.paab.ca/about.htm ↩︎
Member Listings. BIOTECanada. Retrieved December 21, 2021, from https://web.archive.org/web/20211221183627/https://www.biotech.ca/about/member-listings/ ↩︎
Member Listings. BIOTECanada. Retrieved December 30, 2024, from https://web.archive.org/web/20241230035335/https://www.biotech.ca/about/member-listings/ ↩︎
Member Listings. BIOTECanada. Retrieved July 14, 2016, from https://web.archive.org/web/20160714185759/https://www.biotech.ca/about/member-listings/ ↩︎
MacKinnon, H. L., & Robson, W. B. P. Annual Report 2017. C.D. Howe Institute. Retrieved November 9, 2022, from https://web.archive.org/web/20221109192109/https://www.cdhowe.org/sites/default/files/2022-04/2017 AR_English_Final_web.pdf ↩︎